Skip to main content
Premium Trial:

Request an Annual Quote

Matthew Posard

Matthew Posard has joined Trovagene as executive vice president and chief commercial officer. He joins the company from Illumina where he was senior vice president and general manager for the company's new and emerging marketing opportunities business. He also has served as the general manager of Illumina's translational and consumer genomics business and vice president of global marketing. Prior to Illumina, he had leadership roles in sales and marketing at Biosite and worked in strategic and product manufacturing at Gen-Probe, now part of Hologic.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.